Saha, A., Gunaratne, A., Xu, L., Scotland, P., Schwartzman, J., Williams, N., … Kurtzberg, J. (2019). Human umbilical cord blood derived cell therapy product, DUOC-01, ameliorates experimental autoimmune encephalomyelitis, a mouse model for multiple sclerosis. In Cytotherapy (Vol. 21, pp. S55–S55). Elsevier BV. https://doi.org/10.1016/j.jcyt.2019.03.425

Saha, A., A. Gunaratne, L. Xu, P. Scotland, J. Schwartzman, N. Williams, J. D. Troy, A. Balber, A. J. Filiano, and J. Kurtzberg. “Human umbilical cord blood derived cell therapy product, DUOC-01, ameliorates experimental autoimmune encephalomyelitis, a mouse model for multiple sclerosis.” In Cytotherapy, 21:S55–S55. Elsevier BV, 2019. https://doi.org/10.1016/j.jcyt.2019.03.425.

Saha A, Gunaratne A, Xu L, Scotland P, Schwartzman J, Williams N, et al. Human umbilical cord blood derived cell therapy product, DUOC-01, ameliorates experimental autoimmune encephalomyelitis, a mouse model for multiple sclerosis. In: Cytotherapy. Elsevier BV; 2019. p. S55–S55.

Saha, A., et al. “Human umbilical cord blood derived cell therapy product, DUOC-01, ameliorates experimental autoimmune encephalomyelitis, a mouse model for multiple sclerosis.” Cytotherapy, vol. 21, no. 5, Elsevier BV, 2019, pp. S55–S55. Crossref, doi:10.1016/j.jcyt.2019.03.425.

Saha A, Gunaratne A, Xu L, Scotland P, Schwartzman J, Williams N, Troy JD, Balber A, Filiano AJ, Kurtzberg J. Human umbilical cord blood derived cell therapy product, DUOC-01, ameliorates experimental autoimmune encephalomyelitis, a mouse model for multiple sclerosis. Cytotherapy. Elsevier BV; 2019. p. S55–S55.